Cell and Gene Therapy News

Dr. Peggy Goodell elected to National Academy of MedicineOct 21, 2019
Dr. Margaret “Peggy” Goodell, chair of the Department of Molecular and Cellular Biology at Baylor College of Medicine, has been elected to the National Academy of Medicine.
Baylor faculty elected National Academy of Inventors fellows Dec 12, 2018
Drs. Mary K. Estes, Bert O’Malley and Huda Zoghbi of Baylor College of Medicine were three of the 148 renowned academic inventors named fellows of the National Academy of Inventors this week.
$5 million grant to expand blood cancer therapy optionsOct 18, 2018
Using a new grant from the Leukemia and Lymphoma Society, a team from Baylor College of Medicine will work to develop more widely applicable targeted cellular therapies for leukemia and lymphoma.
Engineered T cells made to recognize tumor-specific patternsJun 26, 2018
Researchers have found a new way to ensure that engineered T cells can reliably discriminate between normal and malignant cells.
Immunotherapy summit brings together patients, expertsJan 11, 2018
The NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine is hosting a free educational program for cancer patients and their caregivers seeking to learn more about cancer immunotherapy and clinical trials.
Two Baylor College of Medicine faculty members named to National Academy of MedicineOct 17, 2016
Dr. Malcolm Brenner and Dr. Cheryl Walker were elected to membership in the National Academy of Medicine.
Special T cells that target solid tumors offer potential treatment for pediatric and adult cancersSep 14, 2016
A new study by researchers at Baylor College of Medicine and Texas Children’s Cancer Center has shown promising results for the use of adoptive cell-therapies to treat pediatric and adult solid tumor cancers.
One-time treatment rescues lethal metabolic liver disease in miceAug 30, 2016
Researchers have shown in mice that deleting a gene associated with liver disorder tyrosinaemia type I, they can turn the once deadly illness benign.
T cells that target two tumor surface molecules mitigate tumor escape in mouse model of glioblastomaJul 18, 2016
Researchers show a new strategy, based on targeting specific surface molecules, that eliminates most of the cancer cells in a mouse model of glioblastoma.
Baylor, Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatmentJun 17, 2016
Baylor, Cell Medica enter landmark sponsored research collaboration, representing a significant milestone in an effort to develop a new class of life-saving cancer therapy.